Last reviewed · How we verify

NCT04536597: QSJ

Quince Seed Jelly and Breast Milk on Nipple Fissures

Completed NA Last updated 2 September 2020
What this trial tests

NA trial testing Quince seed jelly group in Primiparity in 426 participants. Completed in 10 May 2017.

Timeline
15 October 2015
Primary endpoint
10 May 2017
10 May 2017

Quick facts

Lead sponsorCumhuriyet University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposeprevention
Enrollment426
Start date15 October 2015
Primary completion10 May 2017
Estimated completion10 May 2017

Drugs / interventions tested

Conditions studied

Sponsor

Cumhuriyet University

Who can join

Adults 19 to 49, female only, with Primiparity or Postpartum. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Background: In various experimental or clinical studies, it has been reported that the jelly made from the quince seed is effective in healing wounds (attributed to the antioxidants, which increased fibroblast activity and collagen production, facilitated the formation of granulation tissue and increased blood circulation) and has no side effects or contraindications. Purpose: To evaluates the effects of quince seed jelly and breast milk on nipple fissures. Methods: Randomised controlled experimental study.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Primiparity

Currently open trials in the same condition.

Other Cumhuriyet University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04536597.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing